Salivary Biomarkers of Chronic Pancreatitis

Overview

About this study

The purpose of this study is to discover new ways of diagnosing chronic pancreatitis (CP) earlier in the course of the disease by studying molecules found in saliva.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

18 years of age or older
Able to provide written informed consent
No prior pancreatic surgery.
Chronic pancreatitis (CP), suspected minimal change chronic pancreatitis (MCCP), or pancreatic ductal adenocarcinoma (PDAC) groups: meet study diagnostic criteria
Pancreatic ductal adenocarcinoma (PDAC) group: no prior chemotherapy or radiotherapy for pancreatic cancer.
Normal volunteers: no history of pancreatitis, pancreatic tumors or cysts, or chronic abdominal pain

Exclusion Criteria:

None

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Santhi Swaroop Vege, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Santhi Swaroop Vege, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials